TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TMDX TransMedics Group, Inc.

Closed Good Friday 04-17 16:00:00 EDT

88.24

+2.86

+3.35%

盘后88.40

+0.16+0.18%

19:53 EDT

High88.39	Low84.53	Vol973.25K
Open85.32	D1 Closing85.38	Amplitude4.52%
Mkt Cap2.97B	Tradable Cap2.86B	Total Shares33.66M
T/O84.76M	T/O Rate3.00%	Tradable Shares32.46M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"TMDX","market":"US","secType":"STK","nameCN":"TransMedics Group, Inc.","latestPrice":88.24,"timestamp":1744920000000,"preClose":85.38,"halted":0,"volume":973247,"hourTrading":{"tag":"盘后","latestPrice":88.4,"preClose":88.24,"latestTime":"19:53 EDT","volume":12817,"amount":1132058.7856,"timestamp":1744934039409},"delay":0,"floatShares":32456553,"shares":33662363,"eps":1.009999,"marketStatus":"Closed Good Friday","change":2.86,"latestTime":"04-17 16:00:00 EDT","open":85.32,"high":88.39,"low":84.53,"amount":84756699.19667499,"amplitude":0.04521,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.009999,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1556769600000,"exchange":"NASDAQ","adjPreClose":85.38,"preHourTrading":{"tag":"盘前","latestPrice":85.51,"preClose":85.38,"latestTime":"09:29 EDT","volume":3159,"amount":271508.231475,"timestamp":1744896599999},"postHourTrading":{"tag":"盘后","latestPrice":88.4,"preClose":88.24,"latestTime":"19:53 EDT","volume":12817,"amount":1132058.7856,"timestamp":1744934039409},"volumeRatio":0.7222229644090843,"impliedVol":0.9877,"impliedVolPercentile":0.8287},"requestUrl":"/m/hq/s/TMDX","defaultTab":"news","newsList":[{"id":"2527935378","title":"TransMedics Group (NasdaqGM:TMDX) Surges 20% Over Last Month","url":"https://stock-news.laohu8.com/highlight/detail?id=2527935378","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527935378?lang=en_us&edition=full_marsco","pubTime":"2025-04-13 01:21","pubTimestamp":1744478473,"startTime":"0","endTime":"0","summary":"TransMedics Group (NasdaqGM:TMDX) experienced a 20% price increase over the last month. While the market has generally risen by about 5% in the past week and 4% over the past year, the company's performance stood out in comparison. With market earnings forecasted to grow by 14% annually, it suggests a favorable backdrop for growth-focused stocks. In this context, any significant company announcements or developments could have further supported the stock's positive momentum, further...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/transmedics-group-nasdaqgmtmdx-surges-20-over-last-month","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4082","LU2324357040.USD","BK4588","TMDX","LU2065731478.USD","BK4585"],"gpt_icon":0},{"id":"2525890605","title":"TransMedics Group, Inc. (TMDX): A Bull Case Theory","url":"https://stock-news.laohu8.com/highlight/detail?id=2525890605","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525890605?lang=en_us&edition=full_marsco","pubTime":"2025-04-08 21:20","pubTimestamp":1744118426,"startTime":"0","endTime":"0","summary":"We came across abullish thesison TransMedics Group, Inc.  on Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on TMDX. TransMedics Group, Inc. 's share was trading at $69.15 as of April 7th. TMDX’s trailing and forward P/E were 64.63 and 45.66 respectively according to Yahoo Finance.TransMedics Group, Inc.  is not on our list of the30 Most Popular Stocks Among Hedge Funds. As per our database, 29 hedge fund portfolios held TMDX at the end of the fourth quarter which was 32 in the previous quarter. While we acknowledge the risk and potential of TMDX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than TMDX but that trades at less than 5 times its earnings, check out our report about thecheapest AI stock.Disclosure: None. This article was originally published at Insider Monkey.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/transmedics-group-inc-tmdx-bull-132026080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4082","LU2324357040.USD","LU2065731478.USD","TMDX","BK4585"],"gpt_icon":0},{"id":"2525903078","title":"Trump Tariffs Will Sow Long-term Structural Dislocation, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2525903078","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525903078?lang=en_us&edition=full_marsco","pubTime":"2025-04-08 02:56","pubTimestamp":1744052189,"startTime":"0","endTime":"0","summary":"The Trump administration's \"nonsensical tariffs\" will sow long-term structural dislocation if implemented, Oppenheimer said in a note Monday.\"While we harbor strong views on unfolding chaos with tariff announcements, we will just say, 'You reap what you sow,'\" the firm said.The firm said GE HealthCare Technologies , Varex Imaging , Integer , and Intuitive Surgical  were among the businesses most exposed to tariffs.Intuitive Surgical specifically was at risk for \"significant\" contraction due to its exposure to both China and Mexico, the firm said.\"Our coverage universe is not immune,\" Oppenheimer said.Oppenheimer said it preferred the \"relative safety and diversification\" of stocks like Abbott Laboratories  and Edwards Lifesciences  in the current environment, though cautioned that both businesses faced foreign exchange rate risk.According to the firm, small and mid cap firms with predominantly US exposure such as iRhythm Technologies , TransMedics Group , and AtriCure  were better posi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237957902.USD","LU1023059063.AUD","LU0289739699.SGD","OPY","TMDX","ISRG","ABT.AU","LU1061106388.HKD","LU1868837300.USD","LU0689626769.HKD","LU2065731478.USD","IE00B5TLWC47.USD","LU0029874061.USD","IE00B2B36J28.USD","SG9999002232.USD","LU1815336091.USD","ITGR","BK4568","GEHC","IE0009355771.USD","LU0566484027.USD","IE00B19Z8W00.USD","IE00B19Z8X17.USD","LU1868837136.USD","LU0058720904.USD","LU2106854487.HKD","VREX","LU0238689110.USD","IE00BFXG0V08.USD","EW","LU2468319806.SGD","LU1691799644.USD","LU0097036916.USD","LU1989764664.SGD","IE00BN0W2T93.GBP","LU2125909593.SGD","BK4504","BK4588","LU1914381329.SGD","LU1721429741.USD","LU0079474960.USD","BK4127","LU1868836914.USD","LU1923623000.USD","LU1989763427.SGD","LU2324357040.USD","ATRC","IRTC","LU0266013472.USD","ABT"],"gpt_icon":0},{"id":"2524296253","title":"TransMedics Group And 2 Other Stocks That May Be Trading Below Estimated Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2524296253","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524296253?lang=en_us&edition=full_marsco","pubTime":"2025-04-04 01:08","pubTimestamp":1743700082,"startTime":"0","endTime":"0","summary":"In recent days, the U.S. stock market has experienced significant volatility, with major indices like the Dow Jones and Nasdaq Composite seeing sharp declines following President Trump's announcement of new tariffs on imports. These developments have heightened concerns about inflation and economic growth, leading investors to reassess their strategies in a shifting landscape. In such uncertain times, identifying stocks that may be trading below their estimated value can provide opportunities for investors looking to strengthen their portfolios amidst broader market fluctuations.Top 10 Undervalued Stocks Based On Cash Flows In The United States. TransMedics Group's recent earnings report shows a strong recovery, with net income of US$35.46 million for 2024, reversing a prior year's loss. The stock is trading at US$73.11, significantly below its estimated fair value of US$130.7, suggesting undervaluation based on discounted cash flow analysis. Despite legal challenges alleging misleadin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/transmedics-group-2-other-stocks-170802779.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4134","AVPT","BK4211","LU0274383008.USD","PFS","BK4505","AVPTW","PLMR","BK4195","CINT","BK4220","BK4585","BHLB","BK4082","TMDX","LU1046422090.SGD","BK4114","LU2324357040.USD","BK4588","LU2065731478.USD","ASB"],"gpt_icon":1},{"id":"2524030460","title":"Is Transmedics’ (TMDX) Long-Term Growth Potential Still Intact?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524030460","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524030460?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 20:10","pubTimestamp":1743595832,"startTime":"0","endTime":"0","summary":"Renaissance Investment Management, an investment management company, released its Q4 2024 “Small Cap Growth Strategy” investor letter. A copy of the letter can be downloaded here. The Russell 2000 Growth Index generated a return of 1.7% in the fourth quarter, bringing the yearly returns to 15.2%. The portfolio generated positive returns in the fourth quarter and outperformed the Index. The outperformance was driven by stock selection in Information Technology and underweight position and stock selection in Health Care, while stock selection in Communication Services and Consumer Discretionary detracted. For more information on the fund’s best picks in 2024, please check its top five holdings.Renaissance Investment Management Small Cap Growth Strategy stated the following regarding TransMedics Group, Inc.  in its Q4 2024 investor letter:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/transmedics-tmdx-long-term-growth-121032933.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065731478.USD","MNQmain","BK4023","STRK","SQQQ","QLD","TMDX","USAW.SI","USJW.SI","TSYW.SI","NQmain","BK4516","TQQQ","BK4588","QID","BK4082","NVIW.SI",".IXIC","BK4596","BK4585","BK4600","BK4595","LU2324357040.USD","PSQ"],"gpt_icon":1},{"id":"2524544465","title":"Piper Sandler Remains a Buy on TransMedics Group (TMDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524544465","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524544465?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 18:39","pubTimestamp":1743590381,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-transmedics-group-tmdx-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-transmedics-group-tmdx-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU2324357040.USD","LU2065731478.USD","BK4082","TMDX","BK4588"],"gpt_icon":0},{"id":"2522331875","title":"TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger","url":"https://stock-news.laohu8.com/highlight/detail?id=2522331875","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522331875?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 01:30","pubTimestamp":1743096618,"startTime":"0","endTime":"0","summary":"If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. Ideally, a business will show two trends; firstly a growing return on capital employed  and secondly, an increasing amount of capital employed. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. Speaking of which, we noticed some great changes in TransMedics Group's  returns on capital, so let's have a look.AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.So, TransMedics Group has an ROCE of 5.0%.  Ultimately, that's a low return and it under-performs the Medical Equipment industry average of 10%.If you'd like to know about the risks facing TransMedics Group, we've discovered 2 warning signs that you should","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/transmedics-group-nasdaq-tmdx-might-173018856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","USAW.SI","IE00BKPKM429.USD","TQQQ","IE00BGHQF748.EUR","BK4082","QID","LU2210150020.SGD","EBIT","BK4588","USJW.SI","SQQQ","IE00B3QW5Z07.USD","BK4585","NQmain","LU2095319765.USD","NDAQ","NVIW.SI","BK4112","LU2324357040.USD","MNQmain","TSYW.SI",".IXIC","QLD","LU2210149790.SGD","TMDX","LU2065731478.USD","IE00B64PRP62.GBP"],"gpt_icon":1},{"id":"2522200280","title":"TransMedics Group (TMDX) Missed Expectations Due to Seasonality","url":"https://stock-news.laohu8.com/highlight/detail?id=2522200280","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522200280?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 20:16","pubTimestamp":1742905000,"startTime":"0","endTime":"0","summary":"Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. Small-cap stocks had mixed results in the fourth quarter, failing to match their previous quarter's rebound. The Russell 2000 Growth Index rose 1.70%, outperforming the Russell 2000 Value Index, which fell 1.07%, ending in negative territory. Small caps had a strong year in 2024, with the Russell 2000 Growth Index rising 15.14%, nearly matching the previous year’s results and outperforming the Russell 2000 Value Index, which increased by 8.04% but saw a decline on an annual basis. In addition, please check the fund’s top five holdings to know its best picks in 2024.Carillon Eagle Small Cap Growth Fund stated the following regarding TransMedics Group, Inc.  in its Q4 2024 investor letter:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/transmedics-group-tmdx-missed-expectations-121640084.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ","MNQmain","BK4585","QLD","BK4082","LU2065731478.USD","PSQ","TQQQ","LU2324357040.USD","TMDX","TSYW.SI","BK4588",".IXIC","USJW.SI","USAW.SI","NVIW.SI","NQmain","QID"],"gpt_icon":1},{"id":"2520600522","title":"TransMedics Group (TMDX) Slid as Results Fell Short of Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2520600522","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520600522?lang=en_us&edition=full_marsco","pubTime":"2025-03-17 21:31","pubTimestamp":1742218272,"startTime":"0","endTime":"0","summary":"Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. US small-caps experienced modest gains in Q4, driven by presidential election and anticipated economic growth and less regulation. However, markets fell in December due to higher interest rates. Against this backdrop the strategy gained and outperformed the benchmark Russell 2000 Growth Index, which was up 1.70%. In addition, please check the fund’s top five holdings to know its best picks in 2024.Inanother article, we discussed TransMedics Group, Inc.  and shared the list of worst performing mid cap stocks to buy according to analysts. In addition, please check out our hedge fund investor letters Q4 2024page for more investor letters from hedge funds and other leading investors.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/transmedics-group-tmdx-slid-results-133112193.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TMDX","BK4023","BK4596","BK4082","TSYW.SI","LU2324357040.USD","BK4588","USJW.SI","MNQmain","BK4516","TQQQ","QID","LU2065731478.USD",".IXIC","NQmain","STRK","SQQQ","BK4585","QLD","BK4595","BK4600","PSQ","USAW.SI","NVIW.SI"],"gpt_icon":1},{"id":"2518274113","title":"TransMedics Group Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2518274113","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518274113?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 21:33","pubTimestamp":1741699980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TMDX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 11, 2025 09:33 ET (13:33 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMDX"],"gpt_icon":0},{"id":"1145367826","title":"Stock Track | TransMedics Group Soars 5.22% on Upbeat Q4 Results and Positive Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1145367826","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145367826?lang=en_us&edition=full_marsco","pubTime":"2025-03-05 09:16","pubTimestamp":1741137398,"startTime":"0","endTime":"0","summary":"TransMedics Group, Inc.  saw its stock surge 5.22% in the intraday session on Tuesday, following the company's impressive fourth-quarter 2024 financial results and optimistic guidance for the current year.The medical technology company reported strong revenue growth for Q4 2024, with revenue reaching $122 million, representing a significant increase from the previous year. Additionally, TransMedics recorded a notable jump in net income, climbing to nearly $7 million, a remarkable turnaround from","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | TransMedics Group Soars 5.22% on Upbeat Q4 Results and Positive Outlook","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TMDX"],"gpt_icon":0},{"id":"2517535607","title":"TransMedics Group (NasdaqGM:TMDX) Sees 3% Price Rise As Revenue Hits US$122M In Strong Q4 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2517535607","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517535607?lang=en_us&edition=full_marsco","pubTime":"2025-03-05 01:45","pubTimestamp":1741110348,"startTime":"0","endTime":"0","summary":"TransMedics Group saw its stock price rise by approximately 3% over the past month. This comes amidst the company's strong financial performance in the fourth quarter of 2024, with revenue growing to $122 million and net income increasing to nearly $7 million. Additionally, TransMedics has issued positive revenue guidance for 2025, anticipating a 20% to 25% increase, which likely buoyed investor sentiment. However, the company is also dealing with the implications of a class-action lawsuit alleging fraudulent practices, adding some uncertainty. Despite these challenges, the broader market had a tough month, with significant declines linked to tariffs and economic concerns that contributed to a 2.5% decrease. Yet, TransMedics' gains suggest confidence in its growth prospects, potentially countering broader market pressures. This juxtaposition of company success against market challenges might explain the share price movement.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/transmedics-group-nasdaqgm-tmdx-sees-174548621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TMDX"],"gpt_icon":0},{"id":"2516382678","title":"Piper Sandler Sticks to Its Buy Rating for TransMedics Group (TMDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516382678","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516382678?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 19:49","pubTimestamp":1741088961,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-transmedics-group-tmdx-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-transmedics-group-tmdx-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMDX"],"gpt_icon":0},{"id":"2516065633","title":"Morgan Stanley Reaffirms Their Hold Rating on TransMedics Group (TMDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516065633","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516065633?lang=en_us&edition=full_marsco","pubTime":"2025-03-03 21:08","pubTimestamp":1741007291,"startTime":"0","endTime":"0","summary":"In a report released today, Patrick Wood from Morgan Stanley maintained a Hold rating on TransMedics Group (TMDX – Research Report), with a price t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-reaffirms-their-hold-rating-on-transmedics-group-tmdx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-reaffirms-their-hold-rating-on-transmedics-group-tmdx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMDX"],"gpt_icon":0},{"id":"2516521377","title":"Transmedics Group Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2516521377","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516521377?lang=en_us&edition=full_marsco","pubTime":"2025-03-01 01:54","pubTimestamp":1740765260,"startTime":"0","endTime":"0","summary":"Transmedics Group Inc reports results for the quarter ended December 31 - Earnings SummaryTransmedics Group Inc TMDX.OQ reported quarterly adjusted earnings of 19 cents per share for the quarter ended","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL5N3PJ239:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMDX"],"gpt_icon":1},{"id":"2516437725","title":"Is TransMedics Group, Inc. (TMDX) the Worst Performing Mid Cap Stock to Buy According to Analysts?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516437725","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516437725?lang=en_us&edition=full_marsco","pubTime":"2025-03-01 01:47","pubTimestamp":1740764838,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Worst Performing Mid Cap Stocks to Buy According to Analysts. In this article, we are going to take a look at where TransMedics Group, Inc.  stands against other worst performing mid cap stocks to buy according to analysts.Hall highlighted that interest rates still play a crucial role in market dynamics. Bank of America’s economists expect the Fed to maintain its current stance without further cuts, which could pose refinancing risks for small caps. Mid-caps, on the other hand, have better balance sheets and fundamental trends, which positions them more favorably. Despite the optimism around economic policies and potential deregulation, Hall noted that small caps face a high bar for investor confidence after a decade of underperformance. Historically, small caps are due for an outperformance cycle, and relative valuations suggest they could offer the best price returns over the next decade. However, for this year, investors are cautious about reenteri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/transmedics-group-inc-tmdx-worst-174718928.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USAW.SI","TSYW.SI","BK4082","QID","QLD","TQQQ","SQQQ","USJW.SI","LU2065731478.USD","TMDX","MNQmain",".IXIC","NQmain","BK4588","BK4585","NVIW.SI","PSQ","LU2324357040.USD"],"gpt_icon":1},{"id":"2516088383","title":"TransMedics Stock Rises as Q4 Earnings & Revenues Beat Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2516088383","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516088383?lang=en_us&edition=full_marsco","pubTime":"2025-03-01 00:30","pubTimestamp":1740760200,"startTime":"0","endTime":"0","summary":"TransMedics Group, Inc.TMDX reported fourth-quarter 2024 earnings per share  of 19 cents, which beat the Zacks Consensus Estimate of 18 cents by 5.6%. The company recorded an EPS of 12 cents in the year-ago period.TransMedics registered revenues of $121.6 million, up 49.8% year over year. The figure surpassed the Zacks Consensus Estimate by 10.2%. The year-over-year increase in sales was driven by the rise in utilization of the Organ Care System  across all three organs and additional revenues generated by TransMedics logistics services.Shares of TMDX were up 6.9% during after-hours trading on Feb. 27, likely following the company’s strong quarterly performance. However, the company’s shares have plunged 56.8% in the past six months compared with theindustry’s decline of 2.4%. The S&P 500 Index was up 7% during the same timeframe.TransMedics has three FDA-approved OCS products, each for heart, lung and liver transplantations. TMDX’s OCS products are the only FDA-approved portable, mult","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/transmedics-stock-rises-q4-earnings-163000908.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CAH","RMD","TMDX","BSX","RMD.AU"],"gpt_icon":0},{"id":"2514376322","title":"BUZZ-U.S. STOCKS ON THE MOVE-Recursion Pharmaceuticals, DoubleVerify Holdings, Praxis Precision Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2514376322","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514376322?lang=en_us&edition=full_marsco","pubTime":"2025-02-28 23:46","pubTimestamp":1740757612,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Recursion Pharmaceuticals, DoubleVerify Holdings, Praxis Precision MedicinesEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL3N3PJ1EN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","IE0034224299.USD","HPQ","LU0300736492.USD","LU0130102774.USD","LU1981816686.USD","PRAX","RKT","BK4220","BK4554","KKR","LU0417516902.SGD","BBWI","AU","LU0788108826.HKD","HUT","BK4135","LU0055631609.USD","NEM","LU0359201612.USD","WBA","LU0650527681.SGD","LU1956131251.USD","ACHC","LU1242518857.USD","LU0516423091.SGD","LTH","LU1046422090.SGD","TMDX","OMI","LU1023057109.AUD","APLS","AMRX","DUOL","LU1223083913.SGD","LU1791807156.HKD","LU2039709279.SGD","SG9999001143.SGD","CCCS","ANIP","SG9999002463.SGD","BK4558","LU0329678170.USD","RXRX"],"gpt_icon":1},{"id":"1167932002","title":"Stock Track | TransMedics Group Soars 6.77% in Pre-Market on Stellar Q4 Results, Robust 2025 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1167932002","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167932002?lang=en_us&edition=full_marsco","pubTime":"2025-02-28 22:59","pubTimestamp":1740754748,"startTime":"0","endTime":"0","summary":"TransMedics Group, Inc.  witnessed a significant surge in its stock price, soaring 6.77% in the pre-market session on Friday. This impressive rally was fueled by the company's exceptional fourth-quarter 2024 financial results and a robust outlook for the year 2025.The medical technology company reported better-than-expected earnings and revenue for the fourth quarter. Earnings per share came in at $0.19, surpassing analysts' estimates of $0.18. Revenue skyrocketed 49.83% year-over-year to $121.6","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TMDX"],"gpt_icon":0},{"id":"2514268603","title":"BUZZ-TransMedics climbs on Q4 revenue beat","url":"https://stock-news.laohu8.com/highlight/detail?id=2514268603","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514268603?lang=en_us&edition=full_marsco","pubTime":"2025-02-28 20:35","pubTimestamp":1740746105,"startTime":"0","endTime":"0","summary":"BUZZ-TransMedics climbs on Q4 revenue beat** Medical equipment maker TransMedics' TMDX.O shares rise 4.4% to $75 premarket** Co's Q4 revenue of $121.6 million beats analysts' average expectation of $110.3 million, according to data compiled by LSEG** TMDX forecasts annual revenue between $530 mln and $552 mln, the midpoint of which is above analysts' average estimate of $539 mln - LSEG ** Up to last close, stock down 18.7% in the last 12 months  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL3N3PJ11B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMDX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.transmedics.com","stockEarnings":[{"period":"1week","weight":0.1554},{"period":"1month","weight":0.279},{"period":"3month","weight":0.5427},{"period":"6month","weight":-0.303},{"period":"1year","weight":0.0043},{"period":"ytd","weight":0.4152}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.014205},{"month":2,"riseRate":0.666667,"avgChangeRate":0.165146},{"month":3,"riseRate":0.333333,"avgChangeRate":0.01893},{"month":4,"riseRate":0.666667,"avgChangeRate":0.099435},{"month":5,"riseRate":0.4,"avgChangeRate":0.07653},{"month":6,"riseRate":1,"avgChangeRate":0.175838},{"month":7,"riseRate":0.5,"avgChangeRate":0.003986},{"month":8,"riseRate":0.666667,"avgChangeRate":0.052767},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.108718},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.197398},{"month":11,"riseRate":0.833333,"avgChangeRate":0.241666},{"month":12,"riseRate":0.5,"avgChangeRate":-0.003159}],"exchange":"NASDAQ","name":"TransMedics Group, Inc.","nameEN":"TransMedics Group, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TransMedics Group, Inc.(TMDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TransMedics Group, Inc.,TMDX,TransMedics Group, Inc.股票,TransMedics Group, Inc.股票老虎,TransMedics Group, Inc.股票老虎国际,TransMedics Group, Inc.行情,TransMedics Group, Inc.股票行情,TransMedics Group, Inc.股价,TransMedics Group, Inc.股市,TransMedics Group, Inc.股票价格,TransMedics Group, Inc.股票交易,TransMedics Group, Inc.股票购买,TransMedics Group, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TransMedics Group, Inc.(TMDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction